Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-013590

NPS PHARMACEUTICALS INC · NPSP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joseph J Rogus
Officer — SVP, GTO & Supply Chain Mngmt
Period of report
Feb 21, 2015
Accepted (ET)
Feb 24, 2015 · 9:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 21, 2015U21,663$46.00D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options (right to buy)F1,F7$38.27Feb 21, 2015D11,875D—Feb 12, 2024Common Stock11,8750D
Stock Options (right to buy)F1,F8$8.23Feb 21, 2015D13,068D—Feb 13, 2023Common Stock13,0680D
Stock Options (right to buy)F1,F9$8.21Feb 21, 2015D5,000D—Feb 7, 2022Common Stock5,0000D
Restricted Stock UnitsF4,F2,F3—Feb 21, 2015D4,362D——Common Stock4,3620D
Restricted Stock UnitsF4,F2,F5—Feb 21, 2015D3,136D——Common Stock3,1360D
Restricted Stock UnitsF4,F2,F6—Feb 21, 2015D3,241D——Common Stock3,2410D

Explanation of responses